TotalMarketCap

Kyverna Therapeutics

KYTXNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$284.789 M

$4.61 -10.76%

Close of 6 Nov 2026

As of 6 Nov 2026, Kyverna Therapeutics (KYTX) has a market capitalization of $284.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$161.3M

Loss-making

Shares outstanding

61,843,444

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #83Scribe TherapeuticsSCTX$293.7M
  2. #84AgenusAGEN$290.4M
  3. #85Kyverna TherapeuticsKYTX$284.8M
  4. #86OcugenOCGN$276.5M
  5. #87Precision BiosciencesDTIL$274.7M

What if Kyverna Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$456,586.37

Per share 99,150× higher

Bitcoin $1.53T

$24,705.09

Per share 5,365× higher

Apple $5.02T

$81,104.52

Per share 17,612× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Kyverna Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.